Related Experiment Video
Updated: Feb 6, 2026

Single-cell Gene Expression Using Multiplex RT-qPCR to Characterize Heterogeneity of Rare Lymphoid Populations
Published on: January 19, 2017
Rare single gene disorders: estimating baseline prevalence and outcomes worldwide
Hannah Blencowe1, Sowmiya Moorthie2, Mary Petrou3
1Centre for Maternal, Adolescent, Reproductive, and Child Health, London School of Hygiene and Tropical Medicine, London, UK.
Insights
Rare single gene disorders significantly impact child health, causing morbidity and mortality. This study introduces a method to estimate their collective burden in children up to five years old, aiding public health planning.
Area of Science:
- Genetics
- Pediatrics
- Public Health
Background:
- Non-communicable conditions, including genetic disorders, represent a growing proportion of child mortality and morbidity.
- Current public health programs primarily address common genetic disorders, overlooking the collective impact of rare single gene disorders.
- Rare single gene disorders impose a significant, often underestimated, public health burden on affected families.
Purpose of the Study:
- To develop an approach for estimating the collective frequency and health burden of rare single gene disorders up to age five.
- To provide population-level estimates for policy-makers and program planners in data-scarce settings.
- To aggregate rare single gene disorders into manageable groupings for better burden assessment.
Main Methods:
- Utilizing population-level demographic data.
- Employing assumptions derived from empirical data from settings with available information.
- Estimating the burden of rare single gene disorders in children up to five years of age.
Main Results:
- The study presents a novel approach to estimate the burden of rare single gene disorders.
- This method allows for the quantification of health impact in settings lacking empirical data.
- The findings are intended to inform public health policy and service planning.
Conclusions:
- Rare single gene disorders collectively represent a substantial public health concern.
- The proposed estimation approach can guide resource allocation and intervention strategies.
- Accurate burden estimation is crucial for addressing the needs of children affected by rare genetic conditions.
Abstract:
As child mortality rates overall are decreasing, non-communicable conditions, such as genetic disorders, constitute an increasing proportion of child mortality, morbidity and disability. To date, policy and public health programmes have focused on common genetic disorders. Rare single gene disorders are an important source of morbidity and premature mortality for affected families. When considered collectively, they account for an important public health burden, which is frequently under-recognised. To document the collective frequency and health burden of rare single gene disorders, it is necessary to aggregate them into large manageable groupings and take account of their family implications, effective interventions and service needs. Here, we present an approach to estimate the burden of these conditions up to 5 years of age in settings without empirical data. This approaches uses population-level demographic data, combined with assumptions based on empirical data from settings with data available, to provide population-level estimates which programmes and policy-makers when planning services can use.
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Intrinsically Disordered Proteins
Predicting Reaction Outcomes
What are Estimates?
The estimate for the mean of a sample is denoted by ͞x, whereas the mean of the population is designated as μ. Further, parameters such...
Gene Evolution - Fast or Slow?
In contrast, regions which code...
Outcomes of Glycolysis
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...

